Direxion Daily Technology Bear 3x Shares
TECS

$7.39

8.04%

Market Cap: $125M

0

Funds holding %

of 6,686 funds

–

Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

203% more call options, than puts

Call options by funds: $818K | Put options by funds: $270K

20% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 5

5.55% less ownership

Funds ownership: 19.92% [Q1] → 14.37% (-5.55%) [Q2]

21% less funds holding

Funds holding: 19 [Q1] → 15 (-4) [Q2]

56% less capital invested

Capital invested by funds: $31.1M [Q1] → $13.6M (-$17.5M) [Q2]

57% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 7

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for TECS.

See Analyst Rankings

Financial journalist opinion

Direxion's Ed Egilinsky Talks Small-Caps, Growth & More

Following market uncertainty in August, investors may feel compelled to reassess their portfolio allocations. With potential rate cuts from the Federal Reserve on the horizon, now may be a good time to diversify your portfolio and seek growth strategies.

Direxion's Ed Egilinsky Talks Small-Caps, Growth & More

S&P Volatility Ahead Opens Door for Short-Term Traders

When volatility hits major market indexes, it can spark a sense of angst. But for short-term traders, market fluctuations open the door for opportunities.

S&P Volatility Ahead Opens Door for Short-Term Traders

Q2 Earnings Season Looms Large in Hopes for Broader Stocks Rally

Editor's note: Any and all references to time frames longer than one trading day are for purposes of market context only, and not recommendations of any holding time frame. Daily rebalancing ETFs are not meant to be held unmonitored for long periods.

Q2 Earnings Season Looms Large in Hopes for Broader Stocks Rally

Can Biotech Heal Itself?

Editor's note: Any and all references to time frames longer than one trading day are for purposes of market context only, and not recommendations of any holding time frame. Daily rebalancing ETFs are not meant to be held unmonitored for long periods.

Can Biotech Heal Itself?

Zacks Investment Research

Play These Inverse ETFs on Apparent "AI Fatigue"

Wednesday's massive tech selloff points to near-term uncertainties surrounding AI investments.

Play These Inverse ETFs on Apparent "AI Fatigue"

Top Performing Leveraged/Inverse ETFs: 06/02/2024

These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

Top Performing Leveraged/Inverse ETFs: 06/02/2024

3 Ways Leveraged ETFs Help Traders Navigate Markets

Navigating capital markets requires intangible tools like intuition, mental acuity, and even a bit of luck. Then comes the tangible tools to maximize profit, like leveraged ETFs, which can help traders in a variety of ways.

3 Ways Leveraged ETFs Help Traders Navigate Markets

Keep These 2 ETFs Handy in Case of a Market Correction

When stock market indexes experience sharp drawdowns, it can hit traders swiftly and unexpectedly. That said, market navigators can prepare themselves and potentially profit using inverse ETFs; two ETFs in particular from Direxion Investments.

Keep These 2 ETFs Handy in Case of a Market Correction

Top Performing Leveraged/Inverse ETFs: 04/21/2024

These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.

Top Performing Leveraged/Inverse ETFs: 04/21/2024

Tech Choppiness, Corrections Create Inverse Opportunities

Any sliver of news that feeds into the higher-for-longer interest rates narrative will be an unwelcome guest for tech bulls. For traders looking to feed off bearishness, it's an opportunity to take advantage of inverse exchange traded funds (ETFs).

Tech Choppiness, Corrections Create Inverse Opportunities

See News Rankings